Adverse events3,210

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 3,210

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group A: Adolescents and Adults (3 mg Risdiplam)	0	10	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group A: Adolescents and Adults (5 mg Risdiplam)	0	10	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group A: Adolescents and Adults (Placebo-Control Period Pooled)	0	6	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group B: Children (0.02 mg/kg Risdiplam)	0	7	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group B: Children (0.05 mg/kg Risdiplam)	0	14	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group B: Children (0.15 mg/kg Risdiplam)	0	21	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group B: Children (0.25 mg/kg Risdiplam)	0	7	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group B: Children (Placebo-Control Period Pooled)	0	10	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group A: OLE	1	20	1
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 1 Group B: OLE	0	31	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 2 Placebo-Controlled: Risdiplam	1	120	1
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 2 Placebo-Controlled: Placebo	0	60	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 2 OLT: Risdiplam/Risdiplam	0	117	0
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 2 OLT: Placebo/Risdiplam	1	59	1
other	Iron deficiency anaemia	Blood and lymphatic system disorders	Part 2 OLE: Risdiplam	0	175	0
other	Neutropenia	Blood and lymphatic system disorders	Part 1 Group A: Adolescents and Adults (3 mg Risdiplam)	1	10	1
other	Neutropenia	Blood and lymphatic system disorders	Part 1 Group A: Adolescents and Adults (5 mg Risdiplam)	0	10	0
other	Neutropenia	Blood and lymphatic system disorders	Part 1 Group A: Adolescents and Adults (Placebo-Control Period Pooled)	0	6	0
other	Neutropenia	Blood and lymphatic system disorders	Part 1 Group B: Children (0.02 mg/kg Risdiplam)	0	7	0
other	Neutropenia	Blood and lymphatic system disorders	Part 1 Group B: Children (0.05 mg/kg Risdiplam)	0	14	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02908685/events

API reference For AI assistants

Adverse events3,210

Sources 3

Read this list from software.